10/10/2024Eli Lilly Submits Chinese NDA for Its Anti-IL23 Antibody Mirikizumab

10/10/2024Guangdong Aims to Boost Biopharma Sector to Over CNY 1 Trillion by 202...

10/10/2024Mainland China's Pharmaceutical Sales to Reach $345B by 2033: BMI/Fitc...

10/9/2024US Venture Capital Opens Funding Opportunities for China Biotech Firms

10/9/2024SMEI: Chinese Terminal Drug Market Grew 5.2% in 2023

10/9/2024IQVIA Releases the 2024 White Paper on Development Trends in China's O...

10/8/2024MediLink and Amgen Enter Global Clinical Trial Deal on YL201 Combinat...

10/8/2024Innovent and Ask Pharm Enter Strategic Deal for Limertinib 

10/8/2024Genor Biopharma to Merge with Eddingpharm in Strategic Reverse Takeove...

10/8/2024Zephyrm Bioscience Files for IPO on HKSE with CICC as Sponsor

10/8/2024China to Establish a Unified Mapping Database for Traceability Codes, ...

10/8/2024BeiGene Launches Tevimbra in US, Enters Competitive PD-1 Inhibitor Mar...

10/8/2024CSPC Announces Regulatory Milestones in China and the U.S.

10/8/2024NRDL China: 2024 Outlook (Simon Kucher)

10/3/2024WuXi Considers Asset Sales Amid BIOSECURE Scrutiny: FT

10/3/2024Recent Executive Moves

10/2/2024China Introduces Credit System for Hospital and Pharmacy Staff to Curb...

10/2/2024CDE Solicits Comments on the Proposed Technical Guidelines for Writing...

10/2/2024Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...

10/1/2024HUTCHMED Announces Japan Approval for FRUZAQLA (fruquintinib) Received...

10/1/2024InventisBio Prevails in Trade Secret Misappropriation Lawsuit Filed by...

10/1/2024Alphamab and CSPC Enter a Licensing Deal on Anti-HER2 BsADC JSKN003 in...

10/1/2024Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China

10/1/2024Biotheus to Initiate Phase 3 Trial of BsAb PM8002 for SCLC

10/1/2024Regeneron and Sanofi Announced Chinese Approval of Dupixent as the Fir...

10/1/2024MediLink Registers Phase 3 Trial of Its B7H3 ADC YL201

10/1/2024Lepu Biopharma Files NDA for Lead Product EGFR ADC MRG003

10/1/2024Akeso's Cadonilimab Receives Second Indication Approval from NMPA

10/1/2024Haleon Plans to Raise Stake in Chinese JV to 88%

10/1/2024AFT in China License Deal with Xizang Weixinkang Pharma for Maxigesic ...

Page:22/359 Total number of articles:10756: [First][<<] [20] [21] [22] [23] [24] [>>] [End]